Comprehensive Guide to Managing Type 2 Diabetes with Farxiga and Invokana

Type 2 diabetes is a chronic condition impacting blood sugar regulation, affecting individuals of all ages including children and adults. Its main causes are genetics, obesity, and metabolic issues. Often mild in initial stages, symptoms may go unnoticed without testing. Medications like Farxiga and Invokana are FDA-approved oral treatments proven effective for managing blood sugar levels in Type 2 diabetes. These drugs work by helping the body eliminate excess glucose through urine and require a proper diet and lifestyle adjustments for optimal results.

Farxiga (Dapagliflozin)
FDA approved in January 2014, Farxiga belongs to the SGLT2 inhibitors class. It lowers blood sugar levels but isn't suitable for insulin-dependent individuals. Patients must follow prescribed dosages, adhere to dietary guidelines, and maintain regular exercise. Avoid prolonged use without medical supervision, and monitor blood or urine glucose consistently. Proper storage away from light and moisture helps maintain its efficacy, supported by over 16 clinical trials involving more than 9000 patients.

Invokana (Canagliflozin)
Introduced in 2013 and FDA-approved, Invokana is an SGLT2 inhibitor that helps prevent kidney decline in Type 2 diabetes by promoting glucose elimination via urine. It blocks glucose reabsorption in kidneys, effectively lowering blood sugar levels. As with other treatments, it works best alongside diet and exercise. Combining Invokana with metformin forms Invokamet, also FDA-approved for diabetes management. These medications enable patients to control blood sugar effectively, helping them lead healthier, more normal lives.